Real time PCR: A rapid tool for potency estimation of live attenuated camelpox and buffalopox vaccines

Biologicals

Volumn 40, Issue 1, 2012, Pages 92-95

  Prabhu, M ^a   Siva Sankar, M S ^a   Bhanuprakash, V ^a   Venkatesan, G ^a   Bora, D P ^a   Yogisharadhya, R ^a   Balamurugan, V ^b  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b ICAR NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS   (India)

Author keywords

C18L gene; Camelpox and buffalopox vaccines; Potency; SYBR Green and TaqMan real time PCRs

Indexed keywords

ANKYRIN; BUFFALOPOX VIRUS VACCINE; CAMELPOX VIRUS VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ARTICLE; BUFFALOPOX VIRUS; C18L GENE; CAMELPOX VIRUS; CONTROLLED STUDY; DILUTION; DRUG POTENCY; DRUG SCREENING; INTERMETHOD COMPARISON; POXVIRUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TIME; VIRUS GENE; VIRUS PARTICLE;

ANIMALS; CERCOPITHECUS AETHIOPS; GENES, VIRAL; ORTHOPOXVIRUS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VACCINES, ATTENUATED; VACCINIA; VACCINIA VIRUS; VERO CELLS; VIRAL VACCINES;

BUFFALOPOX VIRUS;

EID: 84856437497     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2011.09.012     Document Type: Article

References (22)

1. Bhanuprakash V., Prabhu M., Venkatesan G., Balamurugan V., Hosamani M., Pathak K.M.L., et al. Camelpox: epidemiology, diagnosis and control measures. Exp Rev Anti-Infect Ther 2010, 8(10):1187-1201.
2. Jezek Z., Kriz B., Rothbaur V. Camelpox and its risk to the human population. JHyg Epi Microbio Immunol 1983, 27:29-42.
3. Singh R.K., Hosamani M., Balamurugan V., Bhanuprakash V., Rasool T.J., Yadav M.P. Buffalopox: an emerging and re-emerging zoonosis. Anim Health Res Rev 2007, 8(1):105-114.
4. Yadav S., Hosamani M., Balamurugan V., Bhanuprakash V., Singh R.K. Partial genetic characterization of viruses isolated from pox-like infection in cattle and buffaloes: evidence of buffalo pox virus circulation in Indian cows. Arch Virol 2010, 155(2):255-261.
5. Bhanuprakash V., Venkatesan G., Balamurugan V., Hosamani M., Yogisharadhya R., Gandhale P., et al. Zoonotic infections of buffalopox in India. Zoonoses Public Health 2010, 57(7-8):e149-155.
6. Venkatesan G., Balamurugan V., Prabhu M., Yogisharadhya R., Bora D.P., Gandhale P.N., et al. Emerging and re-emerging zoonotic buffalopox infection: a severe outbreak in Kolhapur (Maharashtra). India. Vet Ital 2010, 46(4):439-448.
7. Van Regenmortel M.H.V., Fauquet C.M., Bishop D.H.L. Virus taxonomy: seventh report of the international committee on taxonomy of viruses 2000, Academic Press, San Diego.
8. ICTV Virus Taxonomy: 8th Report of the international Committee on Taxonomy of viruses 2005, 123. Academic Press. C.M. Fauquet, M.A. Mayo, J. Maniloff, U. Desselberger, L.A. Ball (Eds.).
9. Schalk J.A., de Vries C.G., Jongen P.M. Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay. Biologicals 2005, 33:71-79.
10. Gaush C.R., Smith T.F. Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl Microbiol 1968, 16(4):588-594.
11. Forsey T., Heath A.B., Minor P.D. Acollaborative study to assess the proficiency of laboratory estimates of potency of live measles vaccines. Biologicals 1992, 20:233-234.
12. Forsey T., Heath A.B., Minor Pd AEuropean collaborative study to assess the proficiency of laboratory estimates of potency of live measles, mumps and rubella tri-valent vaccines. Biologicals 1993, 21:239-249.
13. Fukuda A., Sengun F., Sarpay H.E., Konobe T., Saito S., Umino Y., et al. Parameters for plaque formation in the potency assay of Japanese measles vaccines. JVirol Methods 1996, 61:1-6.
14. Wang F., Puddy A.C., Mathis B.C., Montalvo A.G., Louis A.A., McMackin J.L. Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency. Vaccine 2005, 23:4500-4508.
15. Schalk J.A.C., van den Elzen C., Ovelgonne H., Bass C., Jongen P.M.J.M. Estimation of the number of infectious measles viruses in live vaccines using quantitative real-time PCR. JVirol Methods 2004, 117:179-187.
16. Kallesh D.J., Hosamani M., Balamurugan V., Bhanuprakash V., Yadav V., Singh R.K. AQuantitative PCR: a quality control assay for estimation of viable virus content in live attenuated goatpox vaccine. Indian J Exp Biol 2009, 47(11):911-915.
17. R). JVirol Methods 2006, 131:193-201.
18. Balamurugan V., Bhanuprakash V., Hosamani M., Jayappa K.D., Venkatesan G., Chauhan B., et al. Apolymerase chain reaction strategy for the diagnosis of camelpox. JVet Diagn Invest 2009, 21(2):231-237.
19. Singh R.K., Balamurugan V., Hosamani M., Kallesh D.J., Bhanuprakash V. Sequence analysis of C18L gene of buffalopox virus: PCR strategy for specific detection and differentiation of buffalopox from orthopoxviruses. JVirol Methods 2008, 154(1-2):146-153.
20. Reed L.J., Muench H. Asimple method of estimating fifty percent end point. Am J Hyg 1938, 27:493.
21. Terpstra C., Kroese A.H. Potency control of modified live viral vaccines for veterinary use. Vaccine 1996, 14:570-575.
22. Sastry L., Johnson T., Hobson M.J., Smucker B., Cometta K. Titering lentiviral vectors: Comparison of DNA, RNA and marker expression methods. Gene Ther 2002, 17:1155.